• 11397 Citations
19992021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1999 2019

Filter
Article
2019

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up

Rosenberg, A. J., Rademaker, A. W., Hochster, H. S., Ryan, T., Hensing, T., Shankaran, V., Baddi, L., Mahalingam, D., Mulcahy, M. F. & Benson, A. B., Jan 1 2019, In : Oncologist. 24, 8, p. 1039-e642

Research output: Contribution to journalArticle

oxaliplatin
docetaxel
Esophagogastric Junction
Fluorouracil
Stomach
1 Citation (Scopus)

Failure to administer recommended chemotherapy: Acceptable variation or cancer care quality blind spot?

Ellis, R. J., Schlick, C. J. R., Feinglass, J. M., Mulcahy, M. F., Benson, A. B., Kircher, S. M., Yang, T. D., Odell, D. D., Bilimoria, K. Y. & Merkow, R. P., Jan 1 2019, In : BMJ Quality and Safety.

Research output: Contribution to journalArticle

Quality of Health Care
Optic Disk
Drug Therapy
Neoplasms
Lung Neoplasms

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)

Gibson, M. K., Catalano, P., Kleinberg, L. R., Staley, C. A., Montgomery, E. A., Jimeno, A., Song, W. F., Mulcahy, M. F., Leichman, L. P. & Benson, A. B., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

oxaliplatin
docetaxel
Chemoradiotherapy
Fluorouracil
Adult Respiratory Distress Syndrome
1 Citation (Scopus)

Piloting a financial counseling intervention for patients with cancer receiving chemotherapy

Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M. F., Kalyan, A., Benson III, A. B., Agulnik, M., Mohindra, N. A., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202-E210

Research output: Contribution to journalArticle

Counseling
Drug Therapy
Neoplasms
Costs and Cost Analysis
Workflow
alpha-Fetoproteins
Hepatocellular Carcinoma
Survival
Research Ethics Committees
ROC Curve

Therasphere yttrium-90 glass microspheres combined with chemotherapy versus chemotherapy alone in second-line treatment of patients with metastatic colorectal carcinoma of the liver: Protocol for the EPOCH phase 3 randomized clinical trial

Chauhan, N., Mulcahy, M. F., Salem, R., Benson III, A. B., Boucher, E., Bukovcan, J., Cosgrove, D., Laframboise, C., Lewandowski, R. J., Master, F., El-Rayes, B., Strosberg, J. R., Sze, D. Y. & Sharma, R. A., Jan 1 2019, In : Journal of medical Internet research. 21, 1, e11545.

Research output: Contribution to journalArticle

Yttrium
Phase III Clinical Trials
Microspheres
Glass
Colorectal Neoplasms
2018
1 Citation (Scopus)

E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors

Lubner, S., Feng, Y., Mulcahy, M. F., O'Dwyer, P., Giang, G. Y., Hinshaw, J. L., Deming, D., Klein, L., Teitelbaum, U., Payne, J., Engstrom, P., Stella, P., Meropol, N. & Benson III, A. B., Sep 1 2018, In : Oncologist. 23, 9, p. 1006-e104

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Disease-Free Survival
Vascular Endothelial Growth Factor A
Fatigue
5 Citations (Scopus)

Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer

Rosenberg, A. J., Wainwright, D. A., Rademaker, A. W., Galvez, C., Genet, M., Zhai, L., Lauing, K. L., Mulcahy, M. F., Hayes, J. P., Odell, D. D., Horbinski, C. M., Komanduri, S., Tetreault, M-P., Kim, K-Y. A. & Villaflor, V. M., May 1 2018, In : Oncotarget. 9, 34, p. 23482-23493 12 p.

Research output: Contribution to journalArticle

Indoleamine-Pyrrole 2,3,-Dioxygenase
Esophageal Neoplasms
Survival
Ligands
Squamous Cell Carcinoma
23 Citations (Scopus)

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

Salem, R., Gabr, A., Riaz, A., Mora, R., Ali, R., Abecassis, M., Hickey, R., Kulik, L., Ganger, D., Flamm, S., Atassi, R., Atassi, B., Sato, K., Benson, A. B., Mulcahy, M. F., Abouchaleh, N., Asadi, A. A., Desai, K., Thornburg, B., Vouche, M. & 7 others, Habib, A., Caicedo, J., Miller, F. H., Yaghmai, V., Kallini, J. R., Mouli, S. & Lewandowski, R. J., Oct 1 2018, In : Hepatology. 68, 4, p. 1429-1440 12 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Hepatocellular Carcinoma
Confidence Intervals
Survival
Therapeutics
2 Citations (Scopus)
Yttrium
Microspheres
Glass
Hepatocellular Carcinoma
Randomized Controlled Trials

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Meropol, N. J., Feng, Y., Grem, J. L., Mulcahy, M. F., Catalano, P. J., Kauh, J. S., Hall, M. J., Saltzman, J. N., George, T. J., Zangmeister, J., Chiorean, E. G., Cheema, P. S., O'Dwyer, P. J. & Benson, A. B., Feb 15 2018, In : Cancer. 124, 4, p. 688-697 10 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Thymidylate Synthase
Colorectal Neoplasms
Research
2017
21 Citations (Scopus)

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Garg, M. K., Zhao, F., Sparano, J. A., Palefsky, J., Whittington, R., Mitchell, E. P., Mulcahy, M. F., Armstrong, K. I., Nabbout, N. H., Kalnicki, S., El-Rayes, B. F., Onitilo, A. A., Moriarty, D. J., Fitzgerald, T. J. & Benson, A. B., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 718-726 9 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Radiology
Anal Canal
Squamous Cell Carcinoma
Papillomaviridae
11 Citations (Scopus)

Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study

Czito, B. G., Deming, D. A., Jameson, G. S., Mulcahy, M. F., Vaghefi, H., Dudley, M. W., Holen, K. D., DeLuca, A., Mittapalli, R. K., Munasinghe, W., He, L., Zalcberg, J. R., Ngan, S. Y., Komarnitsky, P. & Michael, M., Jun 1 2017, In : The Lancet Gastroenterology and Hepatology. 2, 6, p. 418-426 9 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Radiotherapy
Safety
Maximum Tolerated Dose
Pharmacokinetics
2016
31 Citations (Scopus)

90Y radioembolization of colorectal hepatic metastases using glass microspheres: Safety and survival outcomes from a 531-patient multicenter study

Hickey, R. M., Lewandowski, R. J., Prudhomme, T., Ehrenwald, E., Baigorri, B., Critchfield, J., Kallini, J., Gabr, A., Gorodetski, B., Geschwind, J. F., Abbott, A., Shridhar, R., White, S. B., Rilling, W. S., Boyer, B., Kauffman, S., Kwan, S., Padia, S. A., Gates, V. L., Mulcahy, M. F. & 4 others, Kircher, S. M., Nimeiri, H. S., Benson III, A. B. & Salem, R., May 1 2016, In : Journal of Nuclear Medicine. 57, 5, p. 665-671 7 p.

Research output: Contribution to journalArticle

Eye Protective Devices
Microspheres
Multicenter Studies
Neoplasm Metastasis
Survival
3 Citations (Scopus)

Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience

Rakhra, S., Strauss, J. B., Robertson, J., McGinn, C. J., Kim, T., Huang, J., Blake, A., Helenowski, I., Hayes, J. P., Mulcahy, M. F. & Small, W., Jun 1 2016, In : Journal of Gastrointestinal Cancer. 47, 2, p. 196-201 6 p.

Research output: Contribution to journalArticle

gemcitabine
Conformal Radiotherapy
Pancreatic Neoplasms
Fluorouracil
Radiotherapy
11 Citations (Scopus)
oxaliplatin
Peripheral Nervous System Diseases
Neoplasms
Hot Temperature
Skin
7 Citations (Scopus)
Hepatocellular Carcinoma
Survival
Liver Neoplasms
Pharmaceutical Preparations
Drug Therapy
117 Citations (Scopus)
Yttrium
Carcinoma
Hepatocellular Carcinoma
Liver Neoplasms
Confidence Intervals
2015
114 Citations (Scopus)

Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

Benson III, A. B., Venook, A. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fenton, M. J., Fuchs, C. S., Grem, J. L., Grothey, A., Hochster, H. S., Hunt, S., Kamel, A., Kirilcuk, N., Leong, L. A., Lin, E., Messersmith, W. A., Mulcahy, M. F. & 14 others, Murphy, J. D., Nurkin, S., Rohren, E., Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Gregory, K. M. & Freedman-Cass, D., Jun 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 6, p. 719-728 10 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Guidelines
Primary Care Physicians
Publications
Survival Rate
2014
14 Citations (Scopus)

25-hydroxyvitamin D levels and survival in advanced pancreatic cancer: Findings from CALGB 80303 (Alliance)

Alliance for Clinical Trials in Oncology, Jan 1 2014, In : Journal of the National Cancer Institute. 106, 8, dju185.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Survival
gemcitabine
Vitamin D
Vitamin D Deficiency
23 Citations (Scopus)
Yttrium
yttrium
Maximum Tolerated Dose
dosage
Liver
140 Citations (Scopus)

Colon cancer, version 3.2014

Benson III, A. B., Venook, A. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fenton, M. J., Fuchs, C. S., Grem, J. L., Hunt, S., Kamel, A., Leong, L. A., Lin, E., Messersmith, W., Mulcahy, M. F., Murphy, J. D., Nurkin, S., Rohren, E. & 11 others, Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Gregory, K. M. & Freedman-Cass, D. A., Jul 1 2014, In : JNCCN Journal of the National Comprehensive Cancer Network. 12, 7, p. 1028-1059 32 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Guidelines
Therapeutics
Continuity of Patient Care
Patient Preference
11 Citations (Scopus)

Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization

Memon, K., Kulik, L. M., Lewandowski, R. J., Wang, E., Wang, J., Ryu, R. K., Hickey, R., Vouche, M., Baker, T., Ganger, D., Gates, V. L., Habib, A., Mulcahy, M. F. & Salem, R., Jan 1 2014, In : Journal of Vascular and Interventional Radiology. 25, 7, p. 1056-1066 11 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Liver Neoplasms
Confidence Intervals
Survival
Fetal Proteins
9 Citations (Scopus)
Hepatocellular Carcinoma
Interviews
Pain
Liver Neoplasms
Quality of Life
15 Citations (Scopus)

Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction

Issaka, R. B., Shapiro, D. M., Parikh, N. D., Mulcahy, M. F., Komanduri, S., Martin, J. A. & Keswani, R. N., Jan 1 2014, In : Surgical endoscopy. 28, 5, p. 1668-1673 6 p.

Research output: Contribution to journalArticle

Gastrostomy
Ascites
Drainage
Neoplasms
Tertiary Care Centers
8 Citations (Scopus)
Magnetic Resonance Angiography
Hepatocellular Carcinoma
Perfusion
Biomarkers
Transplants
11 Citations (Scopus)

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): A trial of the Eastern Cooperative Oncology Group

Ciombor, K. K., Feng, Y., Benson III, A. B., Su, Y., Horton, L., Short, S. P., Kauh, J. S. W., Staley, C., Mulcahy, M. F., Powell, M., Amiri, K. I., Richmond, A. & Berlin, J., Jan 1 2014, In : Investigational New Drugs. 32, 5, p. 1017-1027 11 p.

Research output: Contribution to journalArticle

Doxorubicin
Hepatocellular Carcinoma
Proteasome Endopeptidase Complex
Interleukin-8
Embolism and Thrombosis
40 Citations (Scopus)

Prospective randomized pilot study of Y90 +/- sorafenib as bridge to transplantation in hepatocellular carcinoma

Kulik, L., Vouche, M., Koppe, S., Lewandowski, R. J., Mulcahy, M. F., Ganger, D., Habib, A., Karp, J., Al-Saden, P., Lacouture, M., Cotliar, J., Abecassis, M., Baker, T. & Salem, R., Jan 1 2014, In : Journal of Hepatology. 61, 2, p. 309-317 9 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Transplantation
Transplants
Liver Transplantation
sorafenib
45 Citations (Scopus)

Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy

Lewandowski, R. J., Memon, K., Mulcahy, M. F., Hickey, R. M., Marshall, K., Williams, M., Salzig, K., Gates, V. L., Atassi, B., Vouche, M., Atassi, R., Desai, K. R., Hohlastos, E., Sato, K. T., Habib, A., Kircher, S. M., Newman, S. B., Nimeiri, H. S., Benson III, A. B. & Salem, R., Jan 1 2014, In : European Journal of Nuclear Medicine and Molecular Imaging. 41, 10, p. 1861-1869 9 p.

Research output: Contribution to journalArticle

Yttrium
Neoplasm Metastasis
Colorectal Neoplasms
Drug Therapy
Survival
84 Citations (Scopus)
Segmental Mastectomy
Radiology
Hepatocellular Carcinoma
Radiation
Pathology
60 Citations (Scopus)

β-catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells

Keerthivasan, S., Aghajani, K., Dose, M., Molinero, L., Khan, M. W., Venkateswaran, V., Weber, C., Emmanuel, A. O., Sun, T., Bentrem, D. J., Mulcahy, M. F., Keshavarzian, A., Ramos, E. M., Blatner, N., Khazaie, K. & Gounari, F., Feb 26 2014, In : Science translational medicine. 6, 225, 225ra28.

Research output: Contribution to journalArticle

Catenins
Regulatory T-Lymphocytes
Colitis
Colonic Neoplasms
T-Lymphocytes
2013
98 Citations (Scopus)

Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: A Phase 2 Study

Hardacre, J. M., Mulcahy, M. F., Small, W., Talamonti, M., Obel, J., Krishnamurthi, S., Rocha-Lima, C. S., Safran, H., Lenz, H. J. & Chiorean, E. G., Jan 1 2013, In : Journal of Gastrointestinal Surgery. 17, 1, p. 94-101 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Immunotherapy
gemcitabine
Disease-Free Survival
Survival
97 Citations (Scopus)

A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular Cancer

Zhu, A. X., Finn, R. S., Mulcahy, M. F., Gurtler, J., Sun, W., Schwartz, J. D., Dalal, R. P., Joshi, A., Hozak, R. R., Xu, Y., Ancukiewicz, M., Jain, R. K., Nugent, F. W., Duda, D. G. & Stuart, K., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6614-6623 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Liver Neoplasms
Biomarkers
Monoclonal Antibodies
Confidence Intervals
85 Citations (Scopus)

A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer

Berlin, J., Bendell, J. C., Hart, L. L., Firdaus, I., Gore, I., Hermann, R. C., Mulcahy, M. F., Zalupski, M. M., Mackey, H. M., Yauch, R. L., Graham, R. A., Bray, G. L. & Low, J. A., Jan 1 2013, In : Clinical Cancer Research. 19, 1, p. 258-267 10 p.

Research output: Contribution to journalArticle

HhAntag691
Colorectal Neoplasms
Placebos
Pharmacokinetics
Disease-Free Survival
58 Citations (Scopus)

Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer

Merkow, R. P., Bentrem, D. J., Mulcahy, M. F., Chung, J. W., Abbott, D. E., Kmiecik, T. E., Stewart, A. K., Winchester, D. P., Ko, C. Y. & Bilimoria, K. Y., Dec 1 2013, In : Annals of surgery. 258, 6, p. 847-853 7 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Colonic Neoplasms
Comorbidity
Neoplasms
Pneumonia
288 Citations (Scopus)

Gastric cancer, version 2.2013

Ajani, J. A., Bentrem, D. J., Besh, S., D'Amico, T. A., Das, P., Denlinger, C., Fakih, M. G., Fuchs, C. S., Gerdes, H., Glasgow, R. E., Hayman, J. A., Hofstetter, W. L., Ilson, D. H., Keswani, R. N., Kleinberg, L. R., Korn, W. M., Lockhart, A. C., Meredith, K., Mulcahy, M. F., Orringer, M. B. & 11 others, Posey, J. A., Sasson, A. R., Scott, W. J., Strong, V. E., Varghese, T. K., Warren, G., Washington, M. K., Willett, C., Wright, C. D., McMillian, N. R. & Sundar, H., Jan 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 5, p. 531-546 16 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Lymph Node Excision
Neoplasms
Drug Therapy
Gastrectomy
95 Citations (Scopus)
Hepatocellular Carcinoma
Quality of Life
Therapeutic Embolization
Therapeutics
Sample Size
54 Citations (Scopus)

Localized Colon Cancer, version 3.2013

Benson III, A. B., Bekaii-Saab, T., Chan, E., Chen, Y. J., Choti, M. A., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fakih, M. G., Fenton, M. J., Fuchs, C. S., Grem, J. L., Hunt, S., Kamel, A., Leong, L. A., Lin, E., May, K. S., Mulcahy, M. F., Murphy, K., Rohren, E. & 11 others, Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Small, W., Sofocleous, C. T., Venook, A. P., Willett, C. G., Gregory, K. M. & Freedman-Cass, D. A., Jan 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 5, p. 519-528 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Guidelines
Primary Care Physicians
Practice Guidelines
Survival Rate
109 Citations (Scopus)

Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines

Benson III, A. B., Bekaii-Saab, T., Chan, E., Chen, Y. J., Choti, M. A., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fakih, M. G., Fenton, M. J., Fuchs, C. S., Grem, J. L., Hunt, S., Kamel, A., Leong, L. A., Lin, E., May, K. S., Mulcahy, M. F., Murphy, K., Rohren, E. & 11 others, Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Jr, W. S., Sofocleous, C. T., Venook, A. P., Willett, C. G., Gregory, K. M. & Freedman-Cass, D. A., Feb 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 2, p. 141-152 12 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Guidelines
Continuity of Patient Care
Primary Care Physicians
Practice Guidelines
30 Citations (Scopus)

Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases

Kumthekar, P. U., Grimm, S. A., Avram, M. J., Kaklamani, V., Helenowski, I., Rademaker, A. W., Cianfrocca, M., Gradishar, W. J., Patel, J. D., Mulcahy, M. F., McCarthy, K. & Raizer, J. J., Apr 1 2013, In : Journal of Neuro-Oncology. 112, 2, p. 247-255 9 p.

Research output: Contribution to journalArticle

Pemetrexed
Pharmacokinetics
Neoplasm Metastasis
Brain
Neoplasms
21 Citations (Scopus)

Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

Buijs, M., Reyes, D. K., Pawlik, T. M., Blackford, A. L., Salem, R., Messersmith, W. A., Weekes, C. D., Mulcahy, M. F., Kamel, I. R. & Geschwind, J. F. H., Mar 1 2013, In : Cancer. 119, 5, p. 1042-1049 8 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Safety
Hyponatremia
Leukopenia
Therapeutics
3 Citations (Scopus)

Phase II trial of paclitaxel/cisplatin followed by surgery and adjuvant radiation therapy and 5-fluorouracil/leucovorin for gastric cancer (ECOG E7296)

Bapsi Chakravarthy, A., Catalano, P. J., Mondschein, J. K., Rosenthal, D. I., Haller, D. G., Whittington, R., Spitz, F. R., Wagner, H., Sigurdson, E. R., Tschetter, L. K., Bayer, G. K., Mulcahy, M. F. & Benson III, A. B., Nov 1 2013, In : Gastrointestinal Cancer Research. 5, 6, p. 191-197 7 p.

Research output: Contribution to journalArticle

Leucovorin
Fluorouracil
Stomach Neoplasms
Radiotherapy
Induction Chemotherapy
11 Citations (Scopus)
Disease Progression
Hepatocellular Carcinoma
Clinical Trials
Therapeutics
Yttrium
94 Citations (Scopus)

Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection

Vouche, M., Lewandowski, R. J., Atassi, R., Memon, K., Gates, V. L., Ryu, R. K., Gaba, R. C., Mulcahy, M. F., Baker, T., Sato, K., Hickey, R., Ganger, D., Riaz, A., Fryer, J., Caicedo, J. C., Abecassis, M., Kulik, L. & Salem, R., Nov 1 2013, In : Journal of Hepatology. 59, 5, p. 1029-1036 8 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Radiation
Liver
Hypertrophy
Portal Vein
50 Citations (Scopus)

Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study

Benson III, A. B., Geschwind, J. F., Mulcahy, M. F., Rilling, W., Siskin, G., Wiseman, G., Cunningham, J., Houghton, B., Ross, M., Memon, K., Andrews, J., Fleming, C. J., Herman, J., Nimeiri, H., Lewandowski, R. J. & Salem, R., Oct 1 2013, In : European Journal of Cancer. 49, 15, p. 3122-3130 9 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Neoplasm Metastasis
Liver
Microspheres
Glass
71 Citations (Scopus)
Portal Vein
Disease Progression
Hepatocellular Carcinoma
Thrombosis
Liver
44 Citations (Scopus)

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

Vouche, M., Kulik, L., Atassi, R., Memon, K., Hickey, R., Ganger, D., Miller, F. H., Yaghmai, V., Abecassis, M., Baker, T., Mulcahy, M., Nayar, R., Lewandowski, R. J. & Salem, R., Nov 1 2013, In : Hepatology. 58, 5, p. 1655-1666 12 p.

Research output: Contribution to journalArticle

Necrosis
Hepatocellular Carcinoma
Transplantation
sorafenib
Response Evaluation Criteria in Solid Tumors
37 Citations (Scopus)

Temsirolimus combined with sorafenib in hepatocellular carcinoma: A phase I dose-finding trial with pharmacokinetic and biomarker correlates

Kelley Dr., R. K., Nimeiri, H. S., Munster, P. N., Vergo, M. T., Huang, Y., Li, C. M., Hwang, J., Mulcahy, M. F., Yeh, B. M., Kuhn, P., Luttgen, M. S., Grabowsky, J. A., Stucky-Marshall, L., Korn, W. M., Ko, A. H., Bergsland, E. K., Benson III, A. B. & Venook, A. P., Jul 1 2013, In : Annals of Oncology. 24, 7, p. 1900-1907 8 p., mdt109.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Pharmacokinetics
Biomarkers
Maximum Tolerated Dose
Sirolimus

Treatment of early-stage esophageal adenocarcinoma

Polish, A. & Mulcahy, M. F., Jun 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 6, p. 640-644 5 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Neoadjuvant Therapy
Esophagectomy
Therapeutics
Neoplasms
24 Citations (Scopus)
Neoadjuvant Therapy
Stomach
Adenocarcinoma
Therapeutics
Neoplasms